Abstract
PB0235 Phase 3 Study of the Efficacy, Pharmacokinetics, Immunogenicity and Safety of von Willebrand Factor/Factor VIII Concentrate in Patients with Severe von Willebrand Disease under 6 Years of Age
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have